Skip to main content
. 2015 Nov 5;15:496. doi: 10.1186/s12913-015-1139-y

Table 2.

Discounted base case results

Technologies Total Incremental ICER (£)
Add-on to MET Costs (£) LYs QALYs Costs (£) LYs QALYs Incremental cost per QALY gained
DPP-4i £13,593 14.80 11.83 - - - -
Dapagliflozin £13,809 14.80 11.86 +£216 0.01 +0.032 £6,761

Abbreviations: LYs, life years; QALYs, quality-adjusted life years; ICER incremental cost-effectiveness ratio